Riskpilot← Back to searchSign inGet full accessCOSMEDICA AS
ASActiveOrg 997970152Kristinelundveien 6, 0268 OsloWholesale of perfume and cosmetics · NACE 4645Est. 201211 employeeswww.cosmedica.no
Revenue 2024
NOK 78,9M
+13% vs 2023
EBITDA margin
25.3%
+21% vs 2023
Equity ratio
51.3%
Financial strength
Net profit 2024
NOK 15,9M
+23% vs 2023
| Revenue | NOK 78,9M | +13% |
| EBITDA | NOK 20M | +21% |
| Net profit | NOK 15,9M | +23% |
| Total assets | NOK 60,9M | -16% |
| Equity | NOK 31,2M | -31% |
| Employees | 11 | — |
Legal name
COSMEDICA AS
Org number
997970152
Legal form
Aksjeselskap
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
14. februar 2012
Share capital
NOK 1 000 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Salg av produkter og tjenester innen kosmetikk og helse, samt investeringer i selskaper innenfor bransjene hudpleie og velvære, og annet som natulig faller sammen med dette.
Address
Kristinelundveien 6, 0268 Oslo
Email
info@cosmedica.no
Website
www.cosmedica.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 61 389 | 65 646 | 65 730 | 70 130 | 78 914 |
| Staff expenses | −6 999 | −7 920 | −10 098 | −10 508 | −7 944 |
| EBITDA | 20 967 | 22 064 | 25 409 | 16 510 | 20 001 |
| Depreciation & amort. | −612 | −594 | −545 | −42 | −32 |
| EBIT | 20 355 | 21 470 | 24 864 | 16 468 | 19 968 |
| Net financials | −1 | 3 081 | 8 795 | −8 | 356 |
| Profit before tax | 20 354 | 24 551 | 33 659 | 16 460 | 20 325 |
| Tax | 4 483 | 4 711 | 5 455 | 3 621 | 4 470 |
| Net profit | 15 871 | 19 840 | 28 204 | 12 839 | 15 855 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 41 208 | 52 126 | 61 689 | 72 278 | 60 862 |
| Equity | 14 477 | 19 317 | 32 521 | 45 360 | 31 214 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 26 731 | 32 809 | 29 168 | 26 918 | 29 648 |
| Total debt | 26 731 | 32 809 | 29 168 | 26 918 | 29 648 |
EBITDA margin
25.3%
This company
15.8%
Market median
+60% vs market
20202024
Equity ratio
51.3%
This company
38.2%
Market median
+34% vs market
20202024
Return on equity
50.8%
This company
18.4%
Market median
+176% vs market
20202024
Net profit margin
20.1%
This company
8.1%
Market median
+148% vs market
20202024
Asset turnover
1.30×
This company
1.12×
Market median
+16% vs market
20202024
Debt / equity
0.95×
This company
0.62×
Market median
+53% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LC Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (8) | ||
| Board of Directors | 2026 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Former (5) | ||
| Chairman | 2021 – 2022 | |
| Board of Directors | 2022 – 2025 | |
| Chairman | 2022 – 2025 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2025 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33% | 33% | 2024 | |
| Company | 21% | 21% | 2024 | |
| Company | 13% | 13% | 2024 | |
| Company | 13% | 13% | 2024 | |
| Company | 13% | 13% | 2022 | |
| Company | 10% | 10% | 2024 | |
| Company | 10% | 10% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Numbernine. As
COSMEDICA AS Board members of COSMEDICA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Linda Cecilie Langvik | Chief Executive Officer | 0 companies |
| Frode Haugli | Chairman | 0 companies |
| Marianne Garborg Fjørtoft | Board of Directors | 0 companies |
| Linda Maaseide | Chairman | 0 companies |
| Ole Martin Rørdam | Board of Directors | 0 companies |
| Eirik Iversen | Board of Directors | 0 companies |
| Jan Åge Fjørtoft | Board of Directors | 0 companies |
| Ingrid Opedal | Board of Directors | 0 companies |
| Camilla Vassøy Aarnes | Board of Directors | 0 companies |
| Bjørn Maaseide | Chairman | 0 companies |
| Fredrik Daylemani Sneve | Board of Directors | 0 companies |
| Rune Kenneth Nygård | Board of Directors | 0 companies |
| Ann-Charlotte Malm Hallqvist | Board of Directors | 0 companies |
| Camilla Annie Martinussen | Board of Directors | 0 companies |